IDEX Biometrics ASA
IDXAD
$0.001
$0.000.00%
| 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | 09/30/2023 | |
|---|---|---|---|---|---|
| Revenue | -72.47% | -53.36% | -24.74% | 1.17% | 23.87% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -72.47% | -53.36% | -24.74% | 1.17% | 23.87% |
| Cost of Revenue | -53.96% | -35.44% | -7.18% | 20.44% | 18.49% |
| Gross Profit | -125.82% | -111.46% | -95.49% | -72.52% | 42.56% |
| SG&A Expenses | -39.51% | -34.91% | -30.02% | -25.55% | -22.62% |
| Depreciation & Amortization | 11.54% | 70.55% | 26.76% | 20.93% | -1.16% |
| Other Operating Expenses | -21.63% | -7.02% | 1.63% | 4.06% | 10.70% |
| Total Operating Expenses | -31.96% | -24.14% | -18.37% | -12.63% | -10.91% |
| Operating Income | 25.24% | 19.54% | 17.47% | 14.43% | 14.87% |
| Income Before Tax | 44.28% | 20.02% | 21.94% | 18.51% | 23.40% |
| Income Tax Expenses | 125.76% | 119.67% | 35.48% | 58.33% | -173.33% |
| Earnings from Continuing Operations | 44.09% | 19.82% | 21.93% | 18.47% | 23.76% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 44.09% | 19.82% | 21.93% | 18.47% | 23.76% |
| EBIT | 25.24% | 19.54% | 17.47% | 14.43% | 14.87% |
| EBITDA | 28.90% | 23.48% | 19.03% | 15.76% | 15.62% |
| EPS Basic | 48.04% | 34.92% | 38.33% | 34.59% | 55.02% |
| Normalized Basic EPS | 42.69% | 35.06% | 38.22% | 34.41% | 54.76% |
| EPS Diluted | 49.73% | 32.36% | 36.54% | 33.37% | 53.84% |
| Normalized Diluted EPS | 43.03% | 35.35% | 38.54% | 34.55% | 54.84% |
| Average Basic Shares Outstanding | 9.69% | 15.40% | 18.87% | 17.85% | 55.68% |
| Average Diluted Shares Outstanding | 10.21% | 16.11% | 19.45% | 17.88% | 55.59% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |
